AL (AL) Stock News

iBUYPOWER, a gaming PC system integrator with 25 years of experience, has expanded into the professional workstation market with a new line of prebuilt and custom systems. The company simultaneously enhanced its warranty coverage to three years for both parts and labor, up from two years previously. The workstation lineup ranges from $3,349 to $19,149 and features configurations with Intel Core Ultra, AMD Ryzen, and high-end GPU options including NVIDIA RTX PRO Blackwell.

Parsons Corporation reported a $70 million year-over-year decrease in net income and a 72% decline in adjusted EBITDA for Q2 2026, attributed to portfolio-shaping actions and a joint venture program charge. The disappointing results led to a stock price drop and prompted a securities law compliance investigation by Holzer & Holzer, LLC.

The FDA announced that Capricor Therapeutics' stem cell treatment for Duchenne muscular dystrophy did not meet the objectives of its Phase 3 trial, contradicting the company's claims from the previous year. Following this disclosure, Capricor's stock price declined significantly.

Ferrari N.V. announced Q2 2026 net revenues of €1,938 million (up 8% YoY), operating profit of €605 million with a 31.2% margin, and net profit of €463 million. The company raised its 2026 guidance citing stronger-than-expected personalizations and lower currency headwinds. The order book covers deliveries through 2027, with new model launches including the Ferrari Luce and 12Cilindri Manuale contributing to the company's most complete product lineup in history.

Rosen Law Firm is investigating potential securities claims against Barclays PLC following allegations of materially misleading business information. The investigation was triggered by reports of Barclays' £600 million exposure to failed UK mortgage lender Market Financial Solutions Ltd, which caused Barclays' stock to decline 3.99% on February 27, 2026, and an additional 2.3% on March 2, 2026. Investors who purchased Barclays securities may be eligible to join a class action lawsuit.

A securities class action lawsuit has been filed against BitGo Holdings, Inc. alleging that offering documents and statements made during its January 2026 IPO and through May 2026 contained material misstatements and omissions. Specifically, the lawsuit claims defendants understated risks from declining digital asset prices and made false statements about the company's financial performance and business prospects. Investors who purchased BitGo securities during the class period have until August 7, 2026 to become lead plaintiffs.

Rosen Law Firm reminds GeneDx Holdings Corp. (NASDAQ: WGS) investors who purchased stock between April 16, 2025 and May 4, 2026 of the August 3, 2026 lead plaintiff deadline in a securities class action. The lawsuit alleges GeneDx made false statements regarding the Fabric acquisition's positive impact on the company's financials and operations, when defendants knew of significant viability problems that would negatively impact the business.

Rosen Law Firm is reminding investors who purchased Primoris Services Corporation stock between August 5, 2025 and June 22, 2026 of the September 21, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Primoris made false statements regarding its cost estimation and project oversight processes for fixed-price renewable energy projects, leading to systematic underestimation of costs and risks.

Shareholder class action lawsuits have been filed against Hertz Global Holdings, BitGo Holdings, and Wix.com Ltd., alleging false and misleading statements regarding their business operations and financial conditions. Hertz faces allegations of deteriorating liquidity and misrepresentation of used-car market conditions. Investors who suffered losses during the specified periods are encouraged to contact the law firm.

A shareholder class action lawsuit has been filed against BitGo Holdings, Inc., alleging that the company's IPO offering documents were negligently prepared and contained false or misleading statements. The lawsuit claims BitGo understated risks related to declining digital asset prices and lacked a reasonable basis for statements about financial performance. The deadline to apply as lead plaintiff is August 7, 2026.

Shareholder class action lawsuits have been filed against Wix.com Ltd., Hertz Global Holdings, Inc., and BitGo Holdings, Inc. The Wix lawsuit alleges overstatement of AI product competitiveness and understatement of development costs. Investors who purchased shares during specified periods and experienced losses are encouraged to contact the law firm.

A shareholder class action lawsuit has been filed against PicS N.V. alleging the company made false and misleading statements in its January 2026 IPO offering documents. The allegations include undisclosed deficiencies in credit evaluation procedures, material reclassifications of credit exposures, unreported elevated Stage 3 formation rates, overstated credit models, and undisclosed deterioration in customer credit quality and heightened default risks. The lead plaintiff deadline is August 4, 2026.

Law firm Robbins Geller has filed class action lawsuits against GRAIL, Inc., GPGI, Inc., and Wix.com Ltd., alleging that executives made false and misleading statements to investors. GRAIL investors can seek lead plaintiff status by August 4, 2026, following a 50% stock price decline after the company failed to achieve primary endpoints in its NHS-Galleri cancer screening trial.

Value Line, Inc. reported fiscal year 2026 net income of $21.63 million ($2.30 per share), up 4.6% from the prior year. The company declared a quarterly dividend of $0.35 per share, marking the 12th consecutive year of increases, with an annualized rate of $1.40 per share. Investment gains nearly doubled to $6.43 million, while liquid assets increased 11.7% to $86.47 million and shareholders' equity grew 8.2% to $107.89 million.

Law firm Kaplan Fox is investigating Alignment Healthcare (ALHC) following a whistleblower complaint alleging accounting irregularities where millions in operating expenses were misclassified as capital expenditures, artificially inflating financial metrics including Adjusted EBITDA. The stock fell 16.7% on July 8, 2026, following the disclosure.

Rosen Law Firm is reminding Microsoft investors who purchased stock between May 1, 2025 and January 28, 2026 of an August 11, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges Microsoft made false statements about its Copilot AI products, including undisclosed problems with brand positioning, user experience, and competitive performance, as well as the need for billions in additional capital expenditures and GPU/CPU capacity diversion from Azure services.

A securities fraud lawsuit has been filed against GPGI, Inc. alleging the company misled investors about its acquisition of Husky Technologies Limited, overstating its value and earnings projections while downplaying management fees to Resolute Holdings. Following short seller allegations in February 2026 and disappointing Q4 2025 and Q1 2026 results, GPGI shares declined significantly, with the company cutting 2026 guidance substantially. Investors have until September 14, 2026 to request lead plaintiff appointment.

Rosen Law Firm has filed a class action lawsuit against PROCEPT BioRobotics Corporation on behalf of investors who purchased common stock between February 28, 2024 and February 25, 2026. The lawsuit alleges that PROCEPT made materially false statements regarding its handpiece unit sales and revenues by utilizing an undisclosed discount program that artificially inflated sales figures and created excess inventory of over 10,000 units. The company allegedly failed to disclose these risks and was unable to achieve its 2025 guidance. Investors must move the court by September 22, 2026 to serve as lead plaintiff.

Rosen Law Firm has filed class action lawsuits against Microvast Holdings, Inc. and other companies on behalf of investors who purchased securities during specified periods. The lawsuit alleges that Microvast made materially false and misleading statements regarding margin targets, inventory management, and the completion of facility expansions. Investors who purchased securities during the class period may be eligible for compensation.

Pomerantz LLP is investigating Pentair plc for potential securities fraud following the company's July 14, 2026 announcement of significantly reduced Q2 2026 guidance and full-year 2026 outlook, primarily due to adverse Pool channel inventory conditions. The announcement also included the departure of CFO Nicholas Brazis, and Pentair's stock fell 15% to $64.33 per share on July 15, 2026.

Pomerantz LLP has filed a class action lawsuit against Hertz Global Holdings for alleged securities fraud. The lawsuit stems from Hertz's June 24, 2026 announcement of a $300 million capital raise and 37 million share offering, coupled with disclosure of unexpected losses in the used car market that would significantly reduce second-quarter earnings. The stock fell 40.71% on the news. Investors have until September 22, 2026 to join the class action.

Pomerantz LLP is investigating Alibaba Group Holding Limited for potential securities fraud following two major incidents: Anthropic's accusation that Alibaba obtained illicit access to its Claude AI model through fake accounts, and a $600 million non-prosecution agreement with the U.S. Department of Justice for failing to prevent illegal pharmaceutical sales on its platforms. These disclosures triggered significant stock price declines.

Pomerantz LLP is investigating potential securities fraud claims against VenHub Global, Inc. The investigation follows VenHub's disclosure of severe financial distress in its annual report, including only $864,450 in revenue for FY 2025, a $62.4 million net loss, stockholders' deficit of $10.3 million, and going concern doubts. The company's stock price fell sharply following these disclosures.

Pomerantz LLP is investigating potential securities fraud claims against Omeros Corporation following the company's announcement on June 26, 2026, that the European Medicines Agency's Committee for Medicinal Products for Human Use adopted a negative opinion on the marketing authorization application for narsoplimab for treating TA-TMA. The negative regulatory decision triggered a 19.12% stock price decline, falling $2.05 per share to $8.67.

Pomerantz LLP has filed a class action lawsuit against Microsoft Corporation alleging securities fraud. The lawsuit stems from Microsoft's January 2026 earnings announcement revealing slower-than-expected Azure growth due to capacity constraints diverted to AI/Copilot, massive capital expenditures of $37.5 billion in Q2, and disappointing Copilot adoption at only 15 million seats versus analyst expectations. Subsequent reports revealed functionality issues with Copilot products and market share losses to competitors like Google Gemini, leading to a stock price decline of nearly 10%. Investors have until August 11, 2026 to request Lead Plaintiff status.

Hagens Berman has filed a securities class action lawsuit against PicS N.V. alleging the company made materially false statements in its January 2026 IPO by failing to disclose internal findings of deficient credit evaluation procedures discovered in December 2025. The lawsuit claims these omissions masked severe portfolio deterioration and heightened default risks. Following post-IPO disclosures in March and June 2026, PicS stock plummeted over 50% from its $19.00 IPO price to under $9.00. The lead plaintiff deadline is August 4, 2026.

Hagens Berman is investigating Alignment Healthcare, Inc. (ALHC) following whistleblower allegations that the company engaged in accounting irregularities by misclassifying operating expenses as capital expenditures to artificially inflate EBITDA and financial metrics. The disclosure caused ALHC stock to plunge 16.7% in a single day, marking its worst performance since February 2024.

A securities class action lawsuit has been filed against First Solar, Inc. for allegedly making materially false and misleading statements regarding its capacity to manage U.S. tariff policy impacts and overstating projected performance. The lawsuit covers purchases between February 26, 2025 and February 24, 2026. The lead plaintiff deadline is August 24, 2026.

Law firm Kirby McInerney LLP is investigating ADTRAN Holdings for potential securities fraud following the company's announcement of preliminary Q2 2026 results that significantly missed guidance. ADTRAN reported revenue of $280-282 million and non-GAAP operating margin of 3.5-4.0%, falling short of prior guidance of $283-303 million revenue and 5-9% margin. The company attributed the miss to a project delay from a single customer and elevated component/freight costs. ADTRAN stock declined 14% on the news.

Kirby McInerney LLP has filed a securities fraud class action lawsuit against Insulet Corporation on behalf of investors who purchased securities between February 21, 2025 and May 26, 2026. The lawsuit alleges that Insulet failed to disclose defective manufacturing controls and safety risks. Two significant product corrections were announced in March and May 2026, resulting in substantial stock price declines of approximately 7% and 5% respectively. The deadline to request lead plaintiff appointment is August 31, 2026.